Trial Profile
Phase III US trial of Allergy Therapeutics' grass pollen allergy vaccine, designated Pollinex Quattro Grass.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 06 Jan 2015
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary) ; Monophosphoryl lipid A
- Indications Grass pollen hypersensitivity; Rhinoconjunctivitis; Seasonal allergic rhinitis
- Focus Registrational; Therapeutic Use
- Sponsors Allergy Therapeutics
- 07 Aug 2012 New trial record